Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Cirrhosis
84%
Liver Transplant Recipients
80%
Obese Subjects
79%
Liver Transplantation
78%
Hepatitis C Virus
68%
Liver
61%
Hepatic Fat
57%
Transjugular Intrahepatic Portosystemic Shunt
51%
Liver Disease
49%
Adipose Tissue
43%
Lipoprotein Kinetics
40%
United States
40%
Clinical Outcomes
39%
Renal Disease
38%
Low-density Lipoprotein
38%
Orthotopic Liver Transplantation
37%
Hepatitis C
37%
Obese Men
36%
Hepatitis C Virus Infection
35%
Randomized Placebo-controlled Trial
34%
Nonalcoholic Steatohepatitis
34%
Primary Liver Cancer
34%
Insulin Action
34%
Chronic Kidney Disease
34%
Hepatorenal Syndrome
34%
Alzheimer's Disease
34%
Weight Loss
30%
Low-density Lipoprotein Triglyceride
30%
Solid Organ Transplantation
29%
Confidence Interval
28%
Fibrosis
27%
Sofosbuvir
27%
Insulin Resistance
26%
Hepatocellular Carcinoma
25%
Patient Survival
25%
Gastric Bypass Surgery
24%
Graft Survival
24%
Pretransplant
24%
Decompensated Cirrhosis
24%
Chronic Liver Disease
23%
Insulin Sensitivity
23%
Fatty Acids
22%
Cholangiocarcinoma
22%
Treatment Options
21%
Adult Patients
21%
Liver Tissue
21%
Older Donors
20%
MELD Score
20%
Liver Fibrosis
20%
Medicine and Dentistry
Liver Transplantation
93%
Liver Graft
84%
Liver Cirrhosis
83%
Transplantation
81%
Nonalcoholic Fatty Liver
78%
Liver Disease
55%
Hepatitis C
49%
Hepatitis C Virus
45%
Liver Cancer
34%
Chronic Kidney Disease
34%
Hepatitis B Virus
34%
Transjugular Intrahepatic Portosystemic Shunt
34%
Solid Organ Transplantation
31%
Portal Hypertension
30%
Cholangiocarcinoma
29%
Diseases
28%
Hepatocellular Carcinoma
27%
Combination Therapy
27%
Liver Injury
24%
Adverse Event
24%
Graft Survival
23%
Triacylglycerol
22%
Gastric Bypass Surgery
21%
COVID-19
20%
Chronic Hepatitis B
20%
Placebo
20%
Adipose Tissue
20%
Antiviral Therapy
19%
Hyperbilirubinemia
19%
Antivirus Agent
18%
Very Low Density Lipoprotein
18%
Yttrium 90
17%
Organ Transplantation
17%
Radioembolization
17%
Small Interfering RNA
17%
Hereditary Hemorrhagic Telangiectasia
17%
Emricasan
17%
Acylglycerol Palmitoyltransferase
17%
Liver Dysfunction
17%
Stereotactic Body Radiation Therapy
17%
Virus Capsid
17%
Mortality
17%
Systolic Function
17%
Ideal Body Weight
17%
Fistula
17%
Medicare
17%
Lipidomics
17%
Shared Decision Making
17%
Sarcoidosis
17%
Hepatopulmonary Syndrome
17%